Pharmaceutical

Novo Nordisk outlays $1.09bn to boost GLP-1RA production in Brazil

Novo Nordisk continues its sizeable manufacturing investments to meet increasing drug demands.

Apr 10, 2025 - 06:00
Novo Nordisk outlays $1.09bn to boost GLP-1RA production in Brazil
Novo Nordisk continues its sizeable manufacturing investments to meet increasing drug demands.
Read the original article

Tags:

Previous Article

Pharma CEOs warn EC President of “risk of exodus” to US

Next Article

US to impose tariffs on pharmaceutical imports

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Opinion: Americans are obsessed with health and fitness tracking. It’s time for a data diet

Opinion: Americans are obsessed with health and fitness...

Jan 8, 2024

The fight for control of methadone, addiction treatment’s ‘miracle molecule’

The fight for control of methadone, addiction treatment...

Oct 20, 2023

Overcoming disruptions in the pharmaceutical supply chain 

Overcoming disruptions in the pharmaceutical supply chain 

Sep 19, 2023